Companies /Healthcare

American Well Corporation - Class A

NYSE: AMWL Health Information Services
$14.45
▲ $0.33 (+2.32%) today
Markets open · 12:32pm ET

AMWL at a Glance

Valuation
Market cap
$240.2M
Profitability
Revenue (TTM)
$218.5M
Profit margin
-35.7%
EPS (TTM)
$-4.77
Price
52-week range
$4 – $15
Street target
$12.80
Earnings
Next report
Nov 3, 2026

Headquartered in Boston, MA Fiscal year ends December NYSE: AMWL business.amwell.com

About American Well

American Well Corporation (Amwell) offers payers and health systems a comprehensive SaaS-based, technology-enabled healthcare platform. The platform includes software and services that power clinical programs from Amwell and its partners, enabling patients to access diversified clinical programs across the care continuum. Revenue is generated through subscription-based platform fees and through Amwell Medical Group (AMG) visit revenue for telehealth consultations. The company serves some of the largest and most sophisticated healthcare organizations in the U.S., including the Defense Health Agency. Amwell operates at scale, enabling care for millions of patients, and is increasingly focused on AI-powered care delivery. The company has no debt and is on a trajectory toward positive operating cash flow. Updated

AMWL Coverage

Frequently Asked Questions

What does American Well do?

American Well Corporation (Amwell) offers payers and health systems a comprehensive SaaS-based, technology-enabled healthcare platform.

What is the AMWL stock price target?

The Wall Street consensus 12-month price target for AMWL is $12.80.